These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 27828874)
41. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations. Brusca RM; Hanna DB; Wada NI; Blankson JN; Witt MD; Jacobson LP; Kingsley L; Palella FJ; Budoff M; Brown TT; Anastos K; Lazar JM; Mack WJ; Bacchetti P; Tien PC; Golzar Y; Plankey M; Golub E; Kaplan RC; Post WS HIV Med; 2020 Apr; 21(4):217-227. PubMed ID: 31729142 [TBL] [Abstract][Full Text] [Related]
42. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus. Dultz G; Gerber L; Farnik H; Berger A; Vermehren J; Pleli T; Zeuzem S; Piiper A; Kronenberger B; Waidmann O J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653 [TBL] [Abstract][Full Text] [Related]
43. Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study. Margolick JB; Bream JH; Nilles TL; Li H; Langan SJ; Deng S; Wang R; Wada N; Leng SX J Infect Dis; 2018 Jun; 218(2):249-258. PubMed ID: 29529309 [TBL] [Abstract][Full Text] [Related]
44. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease. Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048 [TBL] [Abstract][Full Text] [Related]
51. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls. Mosepele M; Hemphill LC; Moloi W; Moyo S; Nkele I; Makhema J; Bennett K; Triant VA; Lockman S PLoS One; 2017; 12(6):e0179994. PubMed ID: 28662159 [TBL] [Abstract][Full Text] [Related]
52. Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans. Letizia A; Eller MA; Polyak C; Eller LA; Creegan M; Dawson P; Bryant C; D K; Crowell TA; Lombardi K; Rono E; Robb ML; Michael NL; Maswai J; Ake JA J Infect Dis; 2019 Jan; 219(2):284-294. PubMed ID: 30165548 [TBL] [Abstract][Full Text] [Related]
53. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217 [TBL] [Abstract][Full Text] [Related]
54. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Davis BH; Zarev PV Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200 [TBL] [Abstract][Full Text] [Related]
55. Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon. Kfutwah AK; Ngoupo PA; Sofeu CL; Ndongo FA; Guemkam G; Ndiang ST; Owona F; Penda IC; Tchendjou P; Rouzioux C; Warszawski J; Faye A; Tejiokem MC BMC Infect Dis; 2017 Mar; 17(1):224. PubMed ID: 28335737 [TBL] [Abstract][Full Text] [Related]
56. Zidovudine-Based Treatments Inhibit the Glycosylation of ADAM17 and Reduce CD163 Shedding From Monocytes. Chen S; Wang X; Zhu H; Tang Q; Du W; Cao H; Lai C; Guo W; Fu L; Lu W J Acquir Immune Defic Syndr; 2018 Sep; 79(1):126-134. PubMed ID: 29794822 [TBL] [Abstract][Full Text] [Related]
57. Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women. Fitch KV; Srinivasa S; Abbara S; Burdo TH; Williams KC; Eneh P; Lo J; Grinspoon SK J Infect Dis; 2013 Dec; 208(11):1737-46. PubMed ID: 24041790 [TBL] [Abstract][Full Text] [Related]
58. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs. Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601 [TBL] [Abstract][Full Text] [Related]
59. Brief Report: Higher Peripheral Monocyte Activation Markers Are Associated With Smaller Frontal and Temporal Cortical Volumes in Women With HIV. Kamkwalala AR; Wang X; Maki PM; Williams DW; Valcour VG; Damron A; Tien PC; Weber KM; Cohen MH; Sundermann EE; Meyer VJ; Little DM; Xu Y; Rubin LH J Acquir Immune Defic Syndr; 2020 May; 84(1):54-59. PubMed ID: 31914004 [TBL] [Abstract][Full Text] [Related]
60. Arterial inflammation in patients with HIV. Subramanian S; Tawakol A; Burdo TH; Abbara S; Wei J; Vijayakumar J; Corsini E; Abdelbaky A; Zanni MV; Hoffmann U; Williams KC; Lo J; Grinspoon SK JAMA; 2012 Jul; 308(4):379-86. PubMed ID: 22820791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]